2Vanhaesebroeck B,Alessi DR.The PI3K-PDK1 connection:more than just a road to PKB[J].Biochem J,2000,346(3):561-576.
3Stocker H.Living with lethal PtdInsP3 levels:viability offlies lacking PTEN restored by a PH-doma in mutation inAkt/PKB[J].Science,2002,295(5562):2088-2091
4Sanchez-Lockhart M,Marin E,Graf EB,et al.Cutting edge:CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways[J].J Immunol,2004,173(12):7120-7124.
5Breslin EM,White PC,Shore AM,et al.LY294002 and rapamycin co-operate to inhibit T-cell proliferation[J].Br J Pharmacol,2005,144(6):791-800.
6Okkenhaug K,Vanhaesebroeck B.PI3K in Iymphocyte development,differentiation and activation[J].Nat Rev Immunol,2003,3(4):317-330.
7Wange RL.LAT,the linker for activation of T cells:a bridge between T cell-specific and general signaling pathways[J].Sci STKE,2000,2000(63):Review.
8Lewis CM,Broussard C,Czar MJ,et al.Tec kinases:modulators of lymphocyte signaling and development[J].Curr Opin Immunol,2001,13(3):317-325.
9Bekgam C,Wu S,Avruch J,et al.Intracelluar signalling:PDK1-a kinase at the hub of things[J].Curr Biol,1999,9(3):R93-R96.
10Ballendran A.PDK1,acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxy1 terminus of PRK2[J].Curr Biol,1999,9(8):393-404.
